Detalhe da pesquisa
1.
Non-viral precision T cell receptor replacement for personalized cell therapy.
Nature
; 615(7953): 687-696, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356599
2.
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.
Nature
; 615(7953): 697-704, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890230
3.
Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
J Gene Med
; 12(4): 333-44, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20209485
4.
Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.
Oncoimmunology
; 7(3): e1407898, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399409
5.
Genetic engineering of chimeric antigen receptors using lamprey derived variable lymphocyte receptors.
Mol Ther Oncolytics
; 3: 16026, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27933313
6.
Simplified prototyping of perfusable polystyrene microfluidics.
Biomicrofluidics
; 8(4): 046501, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25379106
7.
Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.
Exp Hematol
; 39(12): 1124-1135.e4, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21906573